Verinder Sharma

Verinder Sharma


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2005 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Verinder SharmaVerinder Sharma
Verinder Sharma
MKMustaq Khan
Mustaq Khan
ASAngela Smith
Angela Smith

7 April 2003 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
Verinder SharmaVerinder Sharma
Verinder Sharma
DMDwight Mazmanian
Dwight Mazmanian


20 June 2013 in Archives of Women's Mental Health
Verified
Journal Article
Closed access
PDF file
CPCarley J. Pope
Carley J. Pope
BXBin Xie
Bin Xie
Verinder SharmaVerinder Sharma
Verinder Sharma
MCM. Karen Campbell
M. Karen Campbell

1 December 2004 in Journal of Affective Disorders
Verified
Journal Article
Closed access
Verinder SharmaVerinder Sharma
Verinder Sharma
ASAngela Smith
Angela Smith
MKMustaq Khan
Mustaq Khan

12 February 2025 in The Canadian Journal of Psychiatry
Verified
Journal Article
Open access
SVSimone Vigod
Simone Vigod
BFBenicio Frey
Benicio Frey
CCCrystal T. Clark
Crystal T. Clark
SGSophie Grigoriadis
Sophie Grigoriadis
LBLucy C. Barker
Lucy C. Barker
RLRyan J. Van Lieshout
Ryan J. Van Lieshout
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) publishes clinical practice guidelines for mood and anxiety disorders. This CANMAT guideline aims to provide comprehensive clinical guidance for the pregnancy and postpartum (perinatal) management of mood, anxiety and related disorders. Methods: CANMAT convened a core editorial group of interdisciplinary academic clinicians and persons with lived experience (PWLE), and 3 advisory panels of PWLE and perinatal health and perinatal mental health clinicians. We searched for systematic reviews of prevention and treatment interventions for perinatal depressive, bipolar, anxiety, obsessive–compulsive and post-traumatic stress disorders (January 2013–October 2023). We prioritized evidence from reviews of randomized controlled trials (RCTs), except for the perinatal safety of medications where reviews of large high-quality observational studies were prioritized due to the absence of RCT data. Targeted searches for individual studies were conducted when systematic reviews were limited or absent. Recommendations were organized by lines of treatment based on CANMAT-defined levels of evidence quality, supplemented by editorial group consensus to balance efficacy, safety, tolerability and feasibility considerations. Results: The guideline covers 10 clinical sections in a question-and-answer format that maps onto the patient care journey: case identification; organization and delivery of care; non-pharmacological (lifestyle, psychosocial, psychological), pharmacological, neuromodulation and complementary and alternative medicine interventions; high-risk clinical situations; and mental health of the father or co-parent. Equity, diversity and inclusion considerations are provided. Conclusions: This guideline's detailed evidence-based recommendations provide clinicians with key information to promote the delivery of effective and safe perinatal mental healthcare. It is hoped that the guideline will serve as a valuable tool for clinicians in Canada and around the world to help optimize clinical outcomes in the area of perinatal mental health. Plain Language Summary Title: The Canadian Network for Mood and Anxiety Treatments 2024 Guideline for Helping People with Mood, Anxiety and Related Disorders During Pregnancy and Postpartum